Press releases
- Press releases
- Browse
Press releases
1st December 2010. Bridgehead International Ltd announced today that it has entered into an agreement with Jouhou Koukai Services LLC, of Tokyo, Japan, to provide certain joint services to clients in the pharmaceutical, medical device and diagnostics sec More
APR has successfully designed and completed the development of Veloderm, an innovative Biotechnology device for wound healing and licensed to Medestea the exclusive worldwide marketing rights More
A technology, developed by researchers at NUI Galway's National Diagnostics Centre supported by Enterprise Ireland and Innogenetics, is now the basis for tests that diagnose bacterial and fungal infections in blood. More
Chronic obstructive pulmonary disease (COPD), a respiratory disease commonly known as chronic bronchitis or emphysema, is the fourth leading cause of death worldwide, but a University of Western Ontario researcher is providing new insight into the disease More
About Cerca Insights
Cerca Insights core business is helping our customers to improve their drug discovery productivity. Cerca Insights is a Contract Research Organisation (CRO) based in Penang, Malaysia. The company commenced operations in 2008 and now More
Cambridge, 4 November 2010 - One Nucleus, the not-for-profit membership company for international life science and healthcare companies, is to launch a series of high level conferences focused on specific technology areas, replacing its annual BioPartneri More
(San Antonio, TX) --- John W. Feik, President and Chief Operating Officer of DFB Pharmaceuticals, Inc. has announced that Paul Johnson has been named President of DPT, DFB's contract manufacturing affiliate. More
Leading pharma partnering event in Portugal confirms reputation of highest business development productivity. More
Bridgehead International, the leading strategic healthcare consultancy, has been honoured with The Queen’s Award for Enterprise 2011, in the International Trade section, for outstanding achievement in international trade. More
An HIV/AIDS vaccine developed at The University of Western Ontario is set for the first phase of human trials.
Sumagen Canada today announced it has submitted an Investigational New Drug application to the United States FDA. More
Sumagen Canada today announced it has submitted an Investigational New Drug application to the United States FDA. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Dec 2008 - 35 pages - $200
Dec 2010 - 15 pages - $500
Dec 2010 - 16 pages - $500
May 2011 - 15 pages - $250
Dec 2010 - 25 pages - $500
Dec 2007 - 65 pages - $3,395
Apr 2008 - 39 pages - $495
Sep 2011 - 30 pages - $250
Sep 2011 - 37 pages - $250
Mar 2011 - 26 pages - $500
Your selection
- Industry sector
- Biotechnology del
Browse By
- Industry sector
- Assay systems
- Diagnostic test systems
- Gene therapy
- Human diagnostics
- Human therapeutics
- Manufacturing
- Nanotechnology
- Other
- Research supplies
- Stem cells
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Year
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us